Integrated Pharmaceuticals Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by JOHNSON CHIN SALLY, was filed 22 Dec 2006.
Integrated Pharmaceuticals Inc: what insiders have been doing
Integrated Pharmaceuticals Inc is a listed company. Its insiders report their share dealings to SEC (Form 4). The past year has been quiet: not a single insider filing for Integrated Pharmaceuticals Inc. The previous disclosure was published on 21 September 2007.
Over the whole record (from 2006), the tally stands at 5 purchases and no sales.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
- 10,000 shares@ US$0.22Common StockSEC:0001072613-07-002209:0
- 3,519 shares@ US$0.284Common StockSEC:0001072613-07-001047:0
- 231,482 shares@ US$0.216Common StockSEC:0001072613-07-000876:0
- 32,191 shares@ US$0.217Common StockSEC:0001072613-07-000870:0
- 250,000 shares@ US$0.06Common StockSEC:0001072613-06-002595:0Canonical exit: 19 Mar 2007 (T+90)
- 14,368 shares@ US$1.74Common StockSEC:0001072613-06-002569:0Canonical exit: 12 Jun 2005 (T+90)
- 104,167 shares@ US$0.24Common StockSEC:0001072613-06-002569:1Canonical exit: 20 Aug 2006 (T+90)
- 996,667 shares@ US$0.06Common StockSEC:0001072613-06-002569:2Canonical exit: 21 Mar 2007 (T+90)
- 2,416,667 shares@ US$0.06Common StockSEC:0001072613-06-002569:3Canonical exit: 21 Mar 2007 (T+90)
9 of 9 declarations
About Integrated Pharmaceuticals Inc
Integrated Pharmaceuticals Inc is a company focused on the development and marketing of pharmaceutical products. It is listed on NASDAQ under the symbol XNAS.